C4 Therapeutics Inc (NASDAQ:CCCC) Receives Different Reactions From Analysts

In the last trading session, 0.52 million shares of the C4 Therapeutics Inc (NASDAQ:CCCC) were traded, and its beta was 3.11. Most recently the company’s share price was $1.62, and it changed around -$0.12 or -6.90% from the last close, which brings the market valuation of the company to $115.03M. CCCC currently trades at a discount to its 52-week high of $7.66, offering almost -372.84% off that amount. The share price’s 52-week low was $1.09, which indicates that the current value has risen by an impressive 32.72% since then.

C4 Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.89. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended CCCC as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.

C4 Therapeutics Inc (NASDAQ:CCCC) trade information

Instantly CCCC has showed a red trend with a performance of -6.90% at the end of last trading. The rise to weekly highs of 1.7900 on recent trading dayincreased the stock’s daily price by 9.5%. On the other hand, C4 Therapeutics Inc (NASDAQ:CCCC) is 17.82% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to increase their stock price by 86.5% from its current value. Analyst projections state that CCCC is forecast to be at a low of $12 and a high of $12.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.92%. C4 Therapeutics Inc earnings are expected to increase by -19.20% in 2025, but the outlook is positive 1.33% per year for the next five years.

CCCC Dividends

C4 Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Feb-26.

RA CAPITAL MANAGEMENT, L.P., with 7.0891% or 4.88 million shares worth $22.54 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.38 shares worth $5.48 million, making up 4.76% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 2.07 shares worth around $3.36 million, which represents about 2.92% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.